Compare LBTYA & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LBTYA | SHC |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | Bermuda | United States |
| Employees | 6820 | N/A |
| Industry | Cable & Other Pay Television Services | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.4B |
| IPO Year | N/A | 2020 |
| Metric | LBTYA | SHC |
|---|---|---|
| Price | $11.64 | $15.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $13.72 | ★ $20.33 |
| AVG Volume (30 Days) | 2.0M | ★ 2.7M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $15.41 | $7.51 |
| Revenue Next Year | $3.03 | $6.00 |
| P/E Ratio | ★ N/A | $171.72 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $9.44 | $10.80 |
| 52 Week High | $13.52 | $19.85 |
| Indicator | LBTYA | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.51 | 51.18 |
| Support Level | $11.43 | $15.18 |
| Resistance Level | $12.16 | $16.55 |
| Average True Range (ATR) | 0.42 | 0.46 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 32.84 | 66.75 |
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.